Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Montenarh

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry|June 16, 2012
Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitroCarolin C Schneider, Sabine Kartarius, Mathias Montenarh, et al.
International Journal of Molecular Sciences|September 11, 2019
Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?Emmanuel Ampofo, Lisa Nalbach, Michael D Menger, et al.
Cellular Signalling|November 19, 2015
The nuclear fraction of protein kinase CK2 binds to the upstream stimulatory factors (USFs) in the absence of DNASarah Spohrer, Elitsa Y Dimova, Thomas Kietzmann, et al.
Biochimica Et Biophysica Acta|May 31, 2015
Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cellsLisa Schwind, Nadine Wilhelm, Sabine Kartarius, et al.
The International Journal of Biochemistry & Cell Biology|July 20, 2010
Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcriptionEmmanuel Ampofo, Thomas Kietzmann, Andreas Zimmer, et al.
Cellular Signalling|May 11, 2017
The mammalian STE20-like kinase 1 (MST1) is a substrate for the apoptosis inhibiting protein kinase CK2Christina Servas, Sandra Kiehlmeier, Julia Hach, et al.
Anticancer Research|January 4, 2012
Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell linesSalma Essa, Sandra Reichrath, Ulrich Mahlknecht, et al.
Biochimica Et Biophysica Acta|February 18, 2014
A new tellurium-containing amphiphilic molecule induces apoptosis in HCT116 colon cancer cellsPeng Du, Nathaniel Edward Bennett Saidu, Johanna Intemann, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|June 12, 2016
Protein Kinase CK2 Regulates Leukocyte-Endothelial Cell Interactions during Ischemia and Reperfusion in Striated Skin MuscleEmmanuel Ampofo, Daniela Widmaier, Mathias Montenarh, et al.
Chemical Research in Toxicology|November 24, 2011
Control of oxidative posttranslational cysteine modifications: from intricate chemistry to widespread biological and medical applicationsClaus Jacob, Eric Battaglia, Torsten Burkholz, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|June 16, 2012
Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitroCarolin C Schneider, Sabine Kartarius, Mathias Montenarh, et al.
International Journal of Molecular Sciences|September 11, 2019
Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?Emmanuel Ampofo, Lisa Nalbach, Michael D Menger, et al.
Cellular Signalling|November 19, 2015
The nuclear fraction of protein kinase CK2 binds to the upstream stimulatory factors (USFs) in the absence of DNASarah Spohrer, Elitsa Y Dimova, Thomas Kietzmann, et al.
Biochimica Et Biophysica Acta|May 31, 2015
Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cellsLisa Schwind, Nadine Wilhelm, Sabine Kartarius, et al.
The International Journal of Biochemistry & Cell Biology|July 20, 2010
Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcriptionEmmanuel Ampofo, Thomas Kietzmann, Andreas Zimmer, et al.
Cellular Signalling|May 11, 2017
The mammalian STE20-like kinase 1 (MST1) is a substrate for the apoptosis inhibiting protein kinase CK2Christina Servas, Sandra Kiehlmeier, Julia Hach, et al.
Anticancer Research|January 4, 2012
Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell linesSalma Essa, Sandra Reichrath, Ulrich Mahlknecht, et al.
Biochimica Et Biophysica Acta|February 18, 2014
A new tellurium-containing amphiphilic molecule induces apoptosis in HCT116 colon cancer cellsPeng Du, Nathaniel Edward Bennett Saidu, Johanna Intemann, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|June 12, 2016
Protein Kinase CK2 Regulates Leukocyte-Endothelial Cell Interactions during Ischemia and Reperfusion in Striated Skin MuscleEmmanuel Ampofo, Daniela Widmaier, Mathias Montenarh, et al.
Chemical Research in Toxicology|November 24, 2011
Control of oxidative posttranslational cysteine modifications: from intricate chemistry to widespread biological and medical applicationsClaus Jacob, Eric Battaglia, Torsten Burkholz, et al.
Pageof 10